Drug Type Small molecule drug |
Synonyms- |
Mechanism 5-HT1B receptor agonists(Serotonin 1b (5-HT1b) receptor agonists), 5-HT1D receptor agonists(Serotonin 1d (5-HT1d) receptor agonists), COX-1 inhibitors(Cyclooxygenase-1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC17H26ClN3O2S |
InChIKeyAWEZYKMQFAUBTD-UHFFFAOYSA-N |
CAS Registry143388-64-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Headache | Phase 3 | - | 01 Dec 2011 | |
Migraine Disorders | Phase 3 | - | 01 Dec 2011 |